Jennifer J Rhodes
General Counsel at Acadia Pharmaceuticals Inc (ACAD)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $245K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Mar 26SEC | ACADAcadia Pharmaceuticals Inc | Sell Plan | 3,84411,280 held (−25%) | $21.47 | $83K | -10.9% |
| Feb 10SEC | ACADAcadia Pharmaceuticals Inc | Sell Plan | 6,9507,609 held (−48%) | $23.38 | $162K | -18.2% |
- Sell
General Counsel Jennifer J Rhodes sold $83K of ACAD at $21.47 — cuts the stake by 25%; pre-scheduled 10b5-1 plan sale.
- Sell
General Counsel Jennifer J Rhodes sold $162K of ACAD at $23.38 — cuts the stake by 48%; pre-scheduled 10b5-1 plan sale.